JNJ-10397049 - Misplaced Pages

Chemical compound Pharmaceutical compound

JNJ-10397049
Clinical data

ATC code	none
Identifiers
IUPAC name 1-(2,4-dibromophenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)urea
CAS Number	708275-58-5
PubChem CID	9869934
IUPHAR/BPS	1701
ChemSpider	8045625
UNII	1B419P24AV
ChEMBL	ChEMBL359632
CompTox Dashboard (EPA)	DTXSID501336831
Chemical and physical data
Formula	C₁₉H₂₀Br₂N₂O₃
Molar mass	484.188 g·mol
3D model (JSmol)	Interactive image
SMILES BrC1=CC=C(NC(N2(C3=CC=CC=C3)OC(C)(C)OC2)=O)C(Br)=C1
InChI InChI=1S/C19H20Br2N2O3/c1-19(2)25-11-16(17(26-19)12-6-4-3-5-7-12)23-18(24)22-15-9-8-13(20)10-14(15)21/h3-10,16-17H,11H2,1-2H3,(H2,22,23,24)/t16-,17-/m0/s1 Key:RBKIJGLHFFQHBE-IRXDYDNUSA-N

JNJ-10397049 is a potent and highly selective OX₂ receptor antagonist. In animals, JNJ-10397049 was found to have sleep-promoting effects and to attenuate the reinforcing effects of ethanol.

References

Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, et al. (July 2009). "Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat". The Journal of Pharmacology and Experimental Therapeutics. 330 (1): 142–51. doi:10.1124/jpet.109.152009. PMID 19363060. S2CID 5676758.
Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, et al. (May 2011). "Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement". Psychopharmacology. 215 (1): 191–203. doi:10.1007/s00213-010-2127-x. PMID 21181123. S2CID 28874886.

v t e Orexin receptor modulators
OX₁	Agonists: AEX-5 AEX-19 AEX-24 Orexin (A, B) Antagonists: ACT-335827 ACT-462206 Almorexant AZD-4041 C4X-3256 (INDV-2000) CR-5542 CVN-766 Daridorexant Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Tebideutorexant (JNJ-61393215) Vornorexant (ORN-0829, TS-142)
OX₂	Agonists: AEX-19 ALKS-2680 Danavorexton (TAK-925) E-2086 Firazorexton (TAK-994) Orexin (A, B) Oveporexton SB-668875 Suntinorexton (TAK-861) Antagonists: ACT-335827 ACT-462206 Almorexant Daridorexant EMPA Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) JNJ-10397049 Lemborexant MK-1064 MK-3697 MK-8133 Seltorexant Suvorexant TCS-1102 TCS-OX2-29 Vornorexant (ORN-0829, TS-142)

This sedative-related article is a stub. You can help Misplaced Pages by expanding it.